# Intrathecal Dexmedetomidine to Decrease Postoperative Nausea and Vomiting and Shivering.

> **NCT05892705** · PHASE4 · COMPLETED · sponsor: **Ain Shams University** · enrollment: 60 (actual)

## Conditions studied

- Intrathecal Dexmedetomidine

## Interventions

- **DRUG:** Dexmedetomidine Injection [Precedex]

## Key facts

- **NCT ID:** NCT05892705
- **Lead sponsor:** Ain Shams University
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2021-06-01
- **Primary completion:** 2023-01-15
- **Final completion:** 2023-01-15
- **Target enrollment:** 60 (ACTUAL)
- **Last updated:** 2023-06-07


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05892705

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05892705, "Intrathecal Dexmedetomidine to Decrease Postoperative Nausea and Vomiting and Shivering.". Retrieved via AI Analytics 2026-06-03 from https://api.ai-analytics.org/clinical/NCT05892705. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*